Clinical Trial Update: Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 feasibility trial of metronomic chemotherapy for locally advanced HER2-negative breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Locally Advanced HER2-negative Breast Cancer | Phase 2 | Status: TERMINATED